Carregant...
Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma...
Guardat en:
| Publicat a: | Cells |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694089/ https://ncbi.nlm.nih.gov/pubmed/33113836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112353 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|